ArticleCellular and molecular life sciences : CMLS2026
Cdkn2a/p16Ink4a loss impairs Spatial memory independently of Alzheimer's-associated genetic pathways in young adult mice.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe cyclin-dependent kinase inhibitor CDKN2A/p16INK4A (p16INK4A) is a central regulator of cellular senescence, widely studied in ageing and cancer. Although its expression increases with age and disease, its role in the adult brain remains poorly defined. Recent evidence suggests a possible contribution to neuroinflammation and cognitive decline in Alzheimer’s disease (AD), but underlying mechanisms are unclear. We investigated the functional impact of p16Ink4a inactivation on spatial cognition and hippocampal gene expression in adult mice under normal and amyloidogenic conditions using the AppNL−G−F AD model.
methodsSpatial learning and memory were assessed using the Morris Water Maze (MWM). Hippocampal transcriptomes from control, p16INK4Aknockout (p16Ink4aKO), AppNL−G−F, and double mutant mice were analysed by RNA sequencing. We performed differential gene expression analysis, gene set enrichment analysis (GSEA), and interaction modelling to assess the molecular consequences of p16Ink4a loss alone and in combination with amyloid pathology.
resultsLoss of p16Ink4a resulted in modest and short-lasting alterations in spatial learning and early memory retrieval, without exacerbating early deficits in AppNL−G−F mice. Transcriptomic analysis indicated that p16Ink4aKO upregulated metabolic, mitochondrial, and translational pathways, while downregulating synaptic and cytoskeletal genes. In contrast, AppNL−G−F mice displayed strong immune activation. The double mutants showed additive transcriptional changes, yet GSEA indicated non-linear interactions in synaptic and immune-related pathways. Unexpectedly, p16Ink4a deletion alone was associated with enrichment of senescence-related signatures.
conclusionConstitutive p16Ink4a loss shows modest effects on spatial memory and broad hippocampal transcriptomic changes, independently of amyloid pathology. These findings point to possible non-canonical roles for p16Ink4a in neuronal homeostasis and emphasise the need for temporally controlled models to better dissect the brain-specific functions of senescence regulators in ageing and neurodegeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.